End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA registry cases

BACKGROUND: The aim of this study was to investigate the characteristics and outcomes of patients receiving renal replacement therapy for end-stage kidney disease (ESKD) secondary to haemolytic uraemic syndrome (HUS). METHODS: The study included all patients with ESKD who commenced renal replacement...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Wen, Mohandas, Janaki, McDonald, Stephen P, Hawley, Carmel M, Badve, Sunil V, Boudville, Neil, Brown, Fiona G, Clayton, Philip A, Wiggins, Kathryn J, Bannister, Kym M, Campbell, Scott B, Johnson, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544575/
https://www.ncbi.nlm.nih.gov/pubmed/23206870
http://dx.doi.org/10.1186/1471-2369-13-164

Ejemplares similares

Ejemplares similares